Skip to main content
OBIO
NASDAQ Industrial Applications And Services

10% Owner RTW Buys $6M of Orchestra BioMed Stock at the $5.00 Offering Price

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$6.23
Mkt Cap
$484.035M
52W Low
$3.46
52W High
$6.5
52W Position info
80% above low
Off High info
4.2% below high
Rel. Volume info
1.6× avg
Market data snapshot near publication time

OBIO sits 80% above its 52-week low of $3.46.

Summary

RTW Investments bought 1.2 million Orchestra BioMed shares at $5.00 for $6 million on 2026-11-09, lifting its stake to 10.76 million shares. The purchase came at the same price as the company's just-closed $86.3M offering.


Key Events · Ownership and Investor Activity · OBIO

  • RTW Buys 1.2M Shares for $6M

    RTW Investments, LP and Roderick Wong reported an open-market purchase of 1,200,000 shares at $5.00 on 2026-11-09, a $6,000,000 transaction.

  • Stake Rises to 10.76M Shares

    Post-transaction holdings total 10,756,063 shares, held indirectly through affiliated RTW funds.

  • Priced at Offering Level

    The $5.00 purchase price matches the price of the underwritten offering that closed 2026-11-09, raising about $86.3 million gross.

  • Follows Discounted Raise

    The offering was priced below the $5.62 last sale, and RTW's buying at that level absorbs part of the new supply.


Analysis · OBIO · Industrial Applications And Services

RTW Investments, the largest outside holder, put $6 million of fresh money into Orchestra BioMed at $5.00 a share — the exact price of the $86.3M offering that closed on 2026-11-09. This is real cash, not an option exercise, and it absorbs a meaningful slice of the newly issued stock. Because the purchase is a 10% owner's allocation rather than an operating executive's bet, it says more about institutional demand for the deal than about day-to-day execution. Still, a holder adding at the deal price right after a discounted raise is a supportive read on the equity story.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, OBIO was trading at $6.23 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $484M. The 52-week trading range was $3.46 to $6.50. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

OBIO - Latest Insights

OBIO
Nov 10, 2026, 4:04 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $5.73
Real-time Price: $6.25 info
Change: +$0.520 (+9%) info
Market Cap: $484.035M info
OBIO
Nov 06, 2026, 5:11 PM EST
Filing Type: 424B5
Importance Score:
8
Price at Filing: $5.68
Real-time Price: $6.25 info
Change: +$0.570 (+10%) info
Market Cap: $484.035M info
OBIO
Nov 05, 2026, 10:43 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $5.00
Real-time Price: $6.25 info
Change: +$1.25 (+25%) info
Market Cap: $484.035M info
OBIO
Nov 05, 2026, 4:01 PM EST
Filing Type: 424B5
Importance Score:
7
Price at Filing: $5.56
Real-time Price: $6.25 info
Change: +$0.690 (+12%) info
Market Cap: $484.035M info
OBIO
Nov 05, 2026, 4:01 PM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $4.70
Real-time Price: $6.25 info
Change: +$1.55 (+33%) info
Market Cap: $484.035M info